Huang BC - Search Results

1

Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis.

Cheng KW, Tseng CH, Chen IJ, Huang BC, Liu HJ, Ho KW, Lin WW, Chuang CH, Huang MY, Leu YL, Roffler SR, Wang JY, Chen YL, Cheng TL. Cheng KW, et al. Among authors: huang bc, huang my. Pharmacol Res. 2022 Mar;177:106115. doi: 10.1016/j.phrs.2022.106115. Epub 2022 Feb 3. Pharmacol Res. 2022. PMID: 35124207

2

Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules.

Lin WW, Cheng YA, Kao CH, Roffler SR, Lee YC, Chen BM, Hsieh YC, Chen IJ, Huang BC, Wang YT, Tung YC, Huang MY, Chen FM, Cheng TL. Lin WW, et al. Among authors: huang bc, huang my. Anal Chem. 2017 Jun 6;89(11):6082-6090. doi: 10.1021/acs.analchem.7b00730. Epub 2017 May 23. Anal Chem. 2017. PMID: 28485140

3

Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy.

Lu YC, Chuang CH, Chuang KH, Chen IJ, Huang BC, Lee WH, Wang HE, Li JJ, Cheng YA, Cheng KW, Wang JY, Hsieh YC, Lin WW, Cheng TL. Lu YC, et al. Among authors: huang bc. PLoS Biol. 2019 Jun 13;17(6):e3000286. doi: 10.1371/journal.pbio.3000286. eCollection 2019 Jun. PLoS Biol. 2019. PMID: 31194726 Free PMC article.

4

Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein.

Huang CC, Cheng KW, Hsieh YC, Lin WW, Cheng CM, Yuan SF, Chen IJ, Cheng YA, Lu YC, Huang BC, Tung YC, Cheng TL. Huang CC, et al. Among authors: huang bc. Sci Rep. 2019 Jul 9;9(1):9931. doi: 10.1038/s41598-019-45160-9. Sci Rep. 2019. PMID: 31289297 Free PMC article.

5

Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity.

Ho KW, Chen IU, Cheng YA, Liao TY, Liu ES, Chen HJ, Lu YC, Su YC, Roffler SR, Huang BC, Liu HJ, Huang MY, Chen CY, Cheng TL. Ho KW, et al. Among authors: huang bc, huang my. J Nanobiotechnology. 2021 Jan 9;19(1):16. doi: 10.1186/s12951-020-00752-w. J Nanobiotechnology. 2021. PMID: 33422061 Free PMC article.

6

Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy.

Lin WW, Cheng YA, Li CC, Ho KW, Chen HJ, Chen IU, Huang BC, Liu HJ, Lu YC, Cheng CM, Huang MY, Lai HW, Cheng TL. Lin WW, et al. Among authors: huang bc, huang my. Sci Rep. 2021 Apr 7;11(1):7598. doi: 10.1038/s41598-021-87271-2. Sci Rep. 2021. PMID: 33828191 Free PMC article.

7

Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy.

Lin WW, Lu YC, Huang BC, Chuang CH, Cheng YA, Chen IJ, Liu HJ, Ho KW, Liao TY, Liu ES, Wu TY, Chang LS, Hong ST, Cheng TL. Lin WW, et al. Among authors: huang bc. Sci Rep. 2021 Jul 21;11(1):14846. doi: 10.1038/s41598-021-94298-y. Sci Rep. 2021. PMID: 34290297 Free PMC article.

8

Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies.

Huang BC, Lu YC, Liao JM, Liu HJ, Hong ST, Hsieh YC, Chuang CH, Chen HJ, Liao TY, Ho KW, Wang YT, Cheng TL. Huang BC, et al. Chem Sci. 2021 Jun 14;12(28):9759-9769. doi: 10.1039/d1sc01748a. eCollection 2021 Jul 21. Chem Sci. 2021. PMID: 34349949 Free PMC article.

9

Correction: Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies.

Huang BC, Lu YC, Liao JM, Liu HJ, Hong ST, Hsieh YC, Chuang CH, Chen HJ, Liao TY, Ho KW, Wang YT, Cheng TL. Huang BC, et al. Chem Sci. 2021 Jul 20;12(30):10395. doi: 10.1039/d1sc90153b. eCollection 2021 Aug 4. Chem Sci. 2021. PMID: 34377426 Free PMC article.

10

A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies.

Hsieh YC, Liao JM, Chuang KH, Ho KW, Hong ST, Liu HJ, Huang BC, Chen IJ, Liu YL, Wang JY, Tsai HL, Su YC, Wang YT, Cheng TL. Hsieh YC, et al. Among authors: huang bc. J Nanobiotechnology. 2022 Jan 31;20(1):58. doi: 10.1186/s12951-022-01259-2. J Nanobiotechnology. 2022. PMID: 35101043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page